Fundz

Quiver Bioscience secures strategic investment from the Porta Family to advance its ASO therapeutic program for Dup15q syndrome.

PRIVATEApr 13, 2026

Round Type

Corporate Round

CambridgeBiotechnologyHealth CareArtificial Intelligence

Investors

Porta Family

Description

Quiver Bioscience announced a targeted investment from the Porta family to support its antisense oligonucleotide (ASO) program for Dup15q syndrome. This investment aims to fund critical safety studies essential for the program's development. The goal is to progress toward meaningful treatments for the Dup15q community. The investment underscores the commitment to addressing unmet medical needs in treating this serious CNS disorder.

Quick answer

Quiver Bioscience raised an undisclosed amount in a Corporate Round round, dated April 13, 2026. Investors: Porta Family. Quiver Bioscience is based in Cambridge, Massachusetts, United States.

How much did Quiver Bioscience raise?
Quiver Bioscience raised an undisclosed amount in a Corporate Round round on April 13, 2026.
Who invested in Quiver Bioscience?
Porta Family is named as investors in this round.
What does Quiver Bioscience do?
Quiver Bioscience is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets.
Where is Quiver Bioscience based and how big is it?
Quiver Bioscience is based in Cambridge, Massachusetts, United States. Fundz records about 43 employees.
Who are the decision-makers at Quiver Bioscience?
Fundz holds 5 contacts at Quiver Bioscience, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Quiver Bioscience that raised within 45 days of this round, from Fundz verified event records.

  • Perceptic raised $12M (Seed) on May 27, 2026.
  • Lucis raised $20M (Series A) on May 26, 2026.
  • Kordata Dynamics raised an undisclosed amount (Pre-Seed) on May 21, 2026.
  • Stride raised $15M (Funding Round) on May 21, 2026.
  • Century Health raised $5M (Seed) on May 19, 2026.
  • Blank Bio raised $7.2M (Seed) on May 19, 2026.

Who to call at Quiver Bioscience, and when

A new round usually means Quiver Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Quiver Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Quiver Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Quiver Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Quiver Bioscience

Location

Cambridge, Massachusetts, United States

About

Quiver Bioscience is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets. Using advanced single-cell imaging and multi-omics, we are building the world's most information-rich neuronal insight map via our "Genomic Positioning System." Our approach integrates cutting-edge scalable human models, state-of-the-art technology and proprietary engineering, and learning and surrogate AI/ML models to identify novel therapeutic targets and the best candidate molecules to deliver new and meaningful therapeutics to patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Quiver Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

5 contacts
Verified contactsPaul R., Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Quiver Bioscience's next move

See what Strategic adds

Quiver Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.